Literature DB >> 22108730

Role of oxidative stress in disease progression in Stage B, a pre-cursor of heart failure.

Arvind Bhimaraj1, W H Wilson Tang.   

Abstract

Oxidative stress represents a persistent imbalance between the production and the compensation of reactive oxygen species. Though predominantly found in advanced heart failure, the most frequent "at-risk" condition has been associated with underlying oxidative stress. It is therefore conceivable that timely detection and early intervention to reduce oxidative stress processes provide an opportunity to prevent disease progression to overt heart failure. This article reviews the current understanding of the current evidence of oxidative stress involvement in the pathophysiology of human heart failure and its potential therapeutic interventions in patients with Stage A and B heart failure. 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22108730      PMCID: PMC3227012          DOI: 10.1016/j.hfc.2011.08.003

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  111 in total

1.  Elevated serum TNF-alpha level as a link between endothelial dysfunction and insulin resistance in normotensive obese patients.

Authors:  G Winkler; P Lakatos; F Salamon; Z Nagy; G Speer; M Kovács; G Harmos; O Dworak; K Cseh
Journal:  Diabet Med       Date:  1999-03       Impact factor: 4.359

2.  Resistin is an inflammatory marker of atherosclerosis in humans.

Authors:  Muredach P Reilly; Michael Lehrke; Megan L Wolfe; Anand Rohatgi; Mitchell A Lazar; Daniel J Rader
Journal:  Circulation       Date:  2005-02-14       Impact factor: 29.690

3.  Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.

Authors:  Eva Lonn; Jackie Bosch; Salim Yusuf; Patrick Sheridan; Janice Pogue; J Malcolm O Arnold; Catherine Ross; Andrew Arnold; Peter Sleight; Jeffrey Probstfield; Gilles R Dagenais
Journal:  JAMA       Date:  2005-03-16       Impact factor: 56.272

4.  Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium.

Authors:  M W Irwin; S Mak; D L Mann; R Qu; J M Penninger; A Yan; F Dawood; W H Wen; Z Shou; P Liu
Journal:  Circulation       Date:  1999-03-23       Impact factor: 29.690

5.  Hypertension and insulin resistance: role of peroxisome proliferator-activated receptor gamma.

Authors:  H Itoh; K Doi; T Tanaka; Y Fukunaga; K Hosoda; G Inoue; H Nishimura; Y Yoshimasa; Y Yamori; K Nakao
Journal:  Clin Exp Pharmacol Physiol       Date:  1999-07       Impact factor: 2.557

6.  Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts.

Authors:  Rogayah Carroll; Andrew N Carley; Jason R B Dyck; David L Severson
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-01-04       Impact factor: 4.310

7.  Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese.

Authors:  Tomohiro Sakamoto; Sunao Kojima; Hisao Ogawa; Hideki Shimomura; Kazuo Kimura; Yasuhiro Ogata; Naritsugu Sakaino; Akira Kitagawa
Journal:  Am J Cardiol       Date:  2006-03-10       Impact factor: 2.778

8.  Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II.

Authors:  K Nakamura; K Fushimi; H Kouchi; K Mihara; M Miyazaki; T Ohe; M Namba
Journal:  Circulation       Date:  1998-08-25       Impact factor: 29.690

Review 9.  Diabetic cardiomyopathy: mechanisms, diagnosis and treatment.

Authors:  Sajad A Hayat; Billal Patel; Rajdeep S Khattar; Rayaz A Malik
Journal:  Clin Sci (Lond)       Date:  2004-12       Impact factor: 6.124

Review 10.  Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress.

Authors:  Anabela P Rolo; Carlos M Palmeira
Journal:  Toxicol Appl Pharmacol       Date:  2006-02-20       Impact factor: 4.219

View more
  6 in total

1.  Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure.

Authors:  Changhai Tian; Lie Gao; Andi Zhang; Bryan T Hackfort; Irving H Zucker
Journal:  J Pharmacol Exp Ther       Date:  2019-10-10       Impact factor: 4.030

2.  Extracellular Vesicles Regulate Sympatho-Excitation by Nrf2 in Heart Failure.

Authors:  Changhai Tian; Lie Gao; Tara L Rudebush; Li Yu; Irving H Zucker
Journal:  Circ Res       Date:  2022-09-13       Impact factor: 23.213

Review 3.  Role of iron homeostasis in the heart : Heart failure, cardiomyopathy, and ischemia-reperfusion injury.

Authors:  Hangying Ying; Zhida Shen; Jiacheng Wang; Binquan Zhou
Journal:  Herz       Date:  2021-05-12       Impact factor: 1.443

Review 4.  Oxygen: how do we stand it?.

Authors:  Irwin Fridovich
Journal:  Med Princ Pract       Date:  2012-06-28       Impact factor: 1.927

5.  Polysaccharides from Hemp Seed Protect against Cyclophosphamide-Induced Intestinal Oxidative Damage via Nrf2-Keap1 Signaling Pathway in Mice.

Authors:  Ran Xue; Ming Du; Tian-Yi Zhou; Wan-Zheng Ai; Zhong-Shan Zhang; Xing-Wei Xiang; Yu-Fang Zhou; Zheng-Shun Wen
Journal:  Oxid Med Cell Longev       Date:  2020-08-25       Impact factor: 6.543

6.  Butein Inhibits Oxidative Stress Injury in Rats with Chronic Heart Failure via ERK/Nrf2 Signaling.

Authors:  Peng Liu; Quanli Pan
Journal:  Cardiovasc Ther       Date:  2022-01-04       Impact factor: 3.023

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.